4-methoxy-e-rhodomycin t

4-Methoxy-E-Rhodomycin T is an experimental small molecule anthracycline, a class of polyketide antibiotics characterized by a tetracenequinone ring structure. It is structurally related to other anthracyclines such as daunorubicin and doxorubicin, which are widely used as anticancer agents. The compound features a methoxy group at the 4-position and is known for its role in studies of biosynthetic pathways involving methyltransferases like DnrK from Streptomyces peucetius. While it has not been approved for clinical use or entered advanced clinical trials, it serves as an important substrate in structural and mechanistic studies of anthracycline biosynthesis[1][3][6][7]. Its mechanism of action would be expected to resemble that of other anthracyclines—intercalation into DNA and inhibition of topoisomerase II—though this specific activity has not been directly confirmed for this analog.

Other names

4-methoxy-ε-rhodomycin t